Share This Link

Dominant antecubital basilic vein: While the basilic vein in the antecubital area is a suitable site, the nondominant arm is generally preferred when possible to minimize interference with the client's activities.

The dorsal venous arch, located on the back of the hand or wrist, is a common site for peripheral IV catheter placement. It is preferred over other sites like the antecubital area due to lower risks of complications such as phlebitis and infiltration. Additionally, using the nondominant hand reduces interference with daily activities.

Dominant distal dorsal vein: The dorsal veins are generally not the first choice for peripheral IV catheter placement due to the potential for complications such as infiltration.

Potassium 4.4 mEq/L: While electrolyte imbalances, particularly low potassium levels, can increase the risk of digoxin toxicity, a potassium level of 4.4 mEq/L is within the normal range and, by itself, does not indicate digoxin toxicity.

Insomnia:Insomnia is not a typical sign of digoxin toxicity. Symptoms of toxicity are more likely to involve the gastrointestinal and visual systems.

Sudden weight gain:Sudden weight gain can be a symptom of heart failure exacerbation but is not a direct indication of digoxin toxicity. Other signs, such as visual disturbances, are more specific to digoxin toxicity.

Inform the client there is a prescription available if needed: This response does not address the urgency indicated by the prescription stating "NOW." It is essential to take immediate action when the prescription indicates an urgent administration.

Notify the pharmacy to send the medication immediately: While timely medication administration is crucial, contacting the pharmacy directly without clarification from the provider may lead to misinterpretation or errors. It's important to confirm the prescription details first.

Administer the medication within 90 minutes: The prescription indicating "NOW" suggests a need for more immediate administration than within 90 minutes. Waiting for 90 minutes may not be in line with the urgency implied by the prescription.

Bradycardia: Bradycardia is not a typical manifestation of an allergic reaction. Allergic reactions are more likely to involve symptoms such as rash, itching, swelling, and cardiovascular symptoms like tachycardia rather than bradycardia.

Polyuria: Polyuria, excessive urine production, is not a typical manifestation of an allergic reaction. Allergic reactions are more likely to involve skin, respiratory, and cardiovascular symptoms.

Nausea: Nausea can be a side effect of medications, but it is not a specific manifestation of an allergic reaction. Allergic reactions are more likely to present with symptoms such as skin rash, itching, or respiratory distress.

Insulin glargine: Insulin glargine is a long-acting insulin used to control blood sugar levels in people with diabetes. However, it is typically not the first-line choice for a client with a new diagnosis of metabolic syndrome and an HbA1c of 6.

Regular insulin: Regular insulin is a short-acting insulin used to control blood sugar levels, but it is not typically the first choice for initial management of metabolic syndrome. It may be considered in certain situations, but other options are often explored first.

Exenatide: Exenatide is a medication that belongs to the class of incretin mimetics and is used to improve blood sugar control. However, it may not be the first choice for initial treatment.

Acetaminophen: This is a common pain reliever and fever reducer. Acetaminophen is often used alongside other medications, including opioids like morphine, to manage pain more effectively. It's typically safe to use with morphine and is not an immediate concern for clarification.

Insulin glargine: Insulin glargine is a long-acting insulin used to control blood sugar levels in individuals with diabetes. While it's important to monitor blood sugar levels in patients receiving opioids, especially if they have diabetes, insulin glargine itself doesn't directly interact with morphine or the PCA pump.

Ondansetron: Ondansetron is an anti-nausea medication commonly used to prevent nausea and vomiting, particularly associated with chemotherapy or surgery. Patients receiving morphine, especially those with cancer, may also be prone to nausea. Ondansetron helps manage this side effect and does not typically interact adversely with morphine.

Dark amber urine: Dark amber urine is not typically an adverse effect of receiving 0.9% sodium chloride solution. It may be a sign of concentrated urine, dehydration, or the presence of certain substances, but it is not a direct adverse effect of the solution itself.

Decreased skin turgor:Decreased skin turgor is a clinical manifestation of dehydration and is not an adverse effect of 0.9% sodium chloride solution. The solution is administered to address dehydration and restore fluid balance.

Increased bowel sounds: Increased bowel sounds are not an adverse effect of 0.9% sodium chloride solution. Bowel sounds are influenced by various factors, including the presence of gas and peristalsis, but they are not directly related to the administration of this isotonic solution.

A vein that feels hard to the touch:A vein that feels hard to the touch may indicate thrombosis or inflammation and is not a suitable site for catheter insertion.

A vein in the client's dominant arm: The choice of arm may depend on the client's preference, but it is not a strict rule. The nurse can choose a suitable vein in either arm based on factors such as accessibility and vein condition.

A vein on the client's wrist: Veins on the wrist may be smaller and more prone to complications. It is generally recommended to choose larger, more accessible veins for catheter insertion.

Orthostatic hypotension: Orthostatic hypotension is not a common adverse effect of pioglitazone. This condition is more associated with medications that affect blood pressure or volume.

Tinnitus: Tinnitus (ringing in the ears) is not typically associated with pioglitazone. Adverse effects of pioglitazone are more related to its impact on glucose metabolism and other metabolic processes.

Insomnia: Insomnia is not a common adverse effect of pioglitazone. Adverse effects are more related to metabolic processes, and sleep disturbances are not typically associated with this medication.

Determine factors that led to the omission: Understanding the factors that led to the omission is crucial for preventing future errors. The nurse should assess if there were any system failures, distractions, or other factors contributing to the missed dose. However, patient's safety and wellbeing comes first.

File an Incident report: Filing an incident report is an important step, but it should not be the first action. The nurse needs to address the immediate situation and assess the factors contributing to the omission first.

Report the missed dosage to the client's provider:Reporting the missed dosage to the provider is an important step, but it should not be the first action. The nurse needs to address the immediate situation, assess the client, and determine factors leading to the omission before reporting to the provider.